Growth hormone treatment in children

Trends in Endocrinology and Metabolism

Volumn 8, Issue 3, 1997, Pages 92-97

  Gertner, Joseph M ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; GLUCOCORTICOID; GONADORELIN AGONIST; OXANDROLONE; RECOMBINANT GROWTH HORMONE; TESTOSTERONE;

BONE DISEASE; CHILD; CHONDROPATHY; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FAMILIAL DISEASE; GROWTH HORMONE DEFICIENCY; GROWTH RETARDATION; HORMONE RESISTANCE; HUMAN; HYPOPHYSIS DISEASE; HYPOTHALAMUS DISEASE; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAUTERINE GROWTH RETARDATION; KIDNEY FAILURE; LEUKEMIA; METABOLIC DISORDER; PRIORITY JOURNAL; SHORT STATURE; SHORT SURVEY; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR RECURRENCE; TURNER SYNDROME;

EID: 0030966199     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(97)00034-9     Document Type: Article

References (53)

1. Albertsson-Wikland K: 1987. The effect of human growth hormone injection frequency on linear growth rate. Acta Paediatr Scand 337(Suppl):110-116.
2. Albertsson-Wikland K, Rosberg S, Libre E, et al.: 1989. Growth hormone secretory rates in children as estimated by deconvolution analysis of 24-h plasma concentration profiles. Am J Physiol 257:E809-E814.
3. Allen DB, Frasier SD, Foley TP, Peskovitz OH: 1993. Growth hormone for children with Down syndrome. J Pediatr 123:742-743.
4. Anonymous: 1995. Guidelines for the use of growth hormone in children with short stature: a report by the Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society. J Pediatr 127:857-867.
5. Appan S, Laurent S, Chapman M, et al.: 1990. Growth and growth hormone therapy in hypochondroplasia. Acta Paediatr Scand 79: 796-803.
6. Bayley N, Pinneau SR: 1952. Tables for predicting adult heights from skeletal ages: revised for use with the Gruelich-Pyle hand system. J Pediatr 40:432-441.
7. Bramswig JH, Schlosser H, Kiese K: 1995. Final height in children with growth hormone deficiency. Horm Res 43:126-128.
8. Burns EC, Tanner JM, Preece MA, Cameron, N: 1981. Final height and pubertal development in 55 children with idiopathic growth hormone deficiency, treated for between 2 and 15 years with human growth hormone. Eur J Pediatr 137:155-164.
9. Caprio S, Boulware SD, Press M, et al.: 1992. Effect of growth hormone treatment on hyperinsulinemia associated with Turner syndrome. J Pediatr 120:238-243.
10. Chavers BM, Doherty L, Nevins T, et al.: 1995. Effects of growth hormone on kidney function in pediatric transplant recipients. Pediatr Nephrol 9:176-181.
11. Cuttler L, Silvers JB, Singh J, et al.: 1996. Short stature and growth hormone therapy: a national study of physician recommendation patterns. JAMA 276:531-537.
12. Donaldson MDC: 1996. Jury still out on growth hormone for normal short stature and Turner's syndrome. Lancet 348:3-4.
13. Fine RN, Kohaut EC, Brown D, Perlman AJ: 1994. Growth after recombinant human growth hormone treatment in children with chronic renal failure: report of a multicenter randomized double-blind placebo-controlled study Genentech Cooperative Study Group. J Pediatr 124:374-382.
14. Fradkin JE, Mills JL, Schonberger LB, et al.: 1993. Risk of leukemia after treatment with pituitary growth hormone. JAMA 270:2829-2832.
15. Frasier SD, Costin G, Lippe, et al.: 1981. A dose-response curve for human growth hormone. J Clin Endocrinol Metab 56:1213-1217.
16. Frisch H, Birnbacher R: 1995. Final height and pubertal development in children with growth hormone deficiency after long-term treatment. Horm Res 43:132-134.
17. Gertner JM, Genel M, Gianfredi SP, et al.: 1984. Prospective clinical trial of human growth hormone in short children without growth hormone deficiency. J Pediatr 104:172-176.
18. Gertner JM, Tamborlane WV, Gianfredi SP, Genel M: 1987. Renewed catch-up growth with increased replacement doses of human growth hormone. J Pediatr 110:425-428.
19. Goddard AD, Covello R, Shiu-Ming L, et al.: 1995. Mutations of the growth hormone receptor in children with idiopathic short stature. N Engl J Med 333:1093-1098.
20. Goeddel DV, Heyneker HL, Hozumi T, et al.: 1979. Direct expression in Escherichia coli of a DNA sequence coding for human growth hormone. Nature 281:544-548.
21. Graves DA: 1996. Utility of the National Cooperative Growth Study database for safety reporting. J Pediatr 128:S1-S3.
22. Guyda HJ: 1994. Use of growth hormone in children with short stature and normal growth hormone secretion: a growing problem. Trends Endocrinol Metab 5:334-340.
23. Hintz RL: 1995. The prismatic case of Creutzfeld-Jakob disease associated with pituitary growth hormone treatment. J Clin Endocrinol Metab 80:2298-2301.
24. Hintz RL, Attie K, Johanson AJ, et al.: 1995. Near final height in GH-treated short children without classical GH deficiency [abst]. Pediatr Res 37:91A.
25. Hopwood NJ, Hintz RL, Gertner JM, et al.: 1993. Growth response of children with non-growth-hormone deficiency and marked short stature during three years of growth hormone therapy. J Pediatr 123:215-222.
26. Kaplan SL, Underwood LE, August GP, et al.: 1986. Clinical studies with recombinant-DNA-derived methionyl human growth hormone in growth hormone deficiency. Lancet 1:697-700.
27. Loche S, Cambiaso P, Setzu S, et al.: 1994. Final height after growth hormone therapy in non-growth hormone deficient children with short stature. J Pediatr 125:196-200.
28. MacGillivray MH, Frohman LA, Doe JD: 1970. Metabolic clearance and production rates of human growth hormone in subjects with normal and abnormal growth. J Clin Endocrinol Metab 30:632-638.
29. MacGillivray MH, Baptista J, Johanson A: 1996. Outcome of a four-year randomized study of daily versus three times weekly somatropin treatment in prepubertal naive growth hormone-deficient children. J Clin Endocrinol Metab 81:1806-1809.
30. Massa G, Otten BJ, de Muinck Keizer-Schrama SM, et al.: 1995. Treatment with two growth hormone regimens in girls with Turner syndrome: final height results Dutch Growth Hormone Working Group. Horm Res 43: 144-146.
31. Mauras N, Blizzard RM, Link K, et al.: 1987. Augmentation of growth hormone secretion during puberty: evidence for a pulse amplitude-modulated phenomenon. J Clin Endocrinol Metab 64:596-601.
32. Moore WV, Moore KC, Gifford R, et al.: 1992. Long term treatment of children with short stature and normal growth hormone secretion. J Pediatr 120:702-708.
33. Moshang T: 1996. Is brain tumor recurrence increased following growth hormone treatment? Trends Endocrinol Metab 6:205-209.
34. Nilsson KO, Albertsson-Wickland K, Alm J, et al.: 1996. Improved final height in girls with turner's syndrome treated with growth hormone and oxandrolone. J Clin Endocrinol Metab 81:635-640.
35. Nishi Y, Kajiyama M, Miyagawa S, et al.: 1993. Growth hormone therapy in achondroplasia. Acta Endocrinol (Copenh) 128:394-396.
36. Ogawa M, Mori O, Kamijo T, et al.: 1988. The occurrence of acute lymphoblastic leukemia shortly after the cessation of human growth hormone therapy. Jpn J Clin Oncol 18:255-260.
37. Ogilvy-Stuart AL, Shalet SM: 1995. Growth and puberty after growth hormone treatment after irradiation for brain tumours. Arch Dis Child 73:141-146.
38. Raben MS: 1958. Treatment of a pituitary dwarf with human growth hormone. J Clin Endocrinol Metab 18:901-903.
39. Ranke MB, Grauer ML: 1994. Adult height in Turner syndrome: results of a multinational survey 1993. Horm Res 42:90-94.
40. Ranke MB, Lindberg A: 1994. Growth hormone treatment of idiopathic short stature: analysis of the database from KIGS, the Kabi Pharmacia International Growth Study. Acta Paediatr Scand Suppl 406:18-23.
41. Rikken B, Massa GG, Wit JM: 1995. Final height in a large cohort of Dutch patients with growth hormone deficiency treated with growth hormone Dutch Growth Hormone Working Group. Horm Res 43:135-137.
42. Rose SR, Ross JL, Uriarte M, et al.: 1988. The advantage of measuring stimulated as compared with spontaneous growth hormone levels in the diagnosis of growth hormone deficiency. N Engl J Med 319:201-207.
43. Rosenfeld RG, Attie KM, Frane J, et al.: 1997. Growth hormone therapy of Turner syndrome: beneficial effect on adult height. J Pediatr 130 (in press).
44. Rosenfeld RG, Albertsson-Wikland K, Cassorla F, et al.: 1995. Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited. J Clin Endocrinol Metab 80:1532-1540.
45. Rotnem D, Cohen DJ, Hintz RL, et al.: 1979. Psychological sequelae of relative "treatment failure" for children receiving human growth hormone replacement. J Am Acad Child Psychiatry 18:505-520.
46. Severi F: 1995. Final height in children with growth hormone deficiency. Horm Res 43: 138-140.
47. Taback SP, Collu R, Deal CL, et al.: 1996. Does growth hormone supplementation affect adult height in Turner's syndrome? Lancet 348:25-27.
48. Takahashi Y, Kaji H, Okimura Y, et al.: 1996. Brief report: short stature caused by a mutant growth hormone. N Engl J Med 334: 432-436.
49. Takano K, Shizume K, Hibi I, et al.: 1995. Long-term effects of growth hormone treatment on height in Turner syndrome: results of a 6-year multicentre study in Japan Committee for the Treatment of Turner Syndrome. Horm Res 43:141-143.
50. Tönshoff B, Dietz M, Haffner D, et al.: 1991. Effects of two years of growth hormone treatment in short children with renal disease. Acta Paediatr Scand 379:33-441.
51. Tönshoff B, Haffner D, Mehls O: 1993. Efficacy and safety of growth hormone treatment in short children with renal allografts: three years experience. Kidney Int 44:199-207.
52. Van den Broeck J, Massa GG, Attanasio A, et al.: 1995. Final height after long-term growth hormone treatment in Turner syndrome European Study Group. J Pediatr 127:729-735.
53. Wilson DM, Lee PD, Morris AH, et al.: 1991. Growth hormone therapy in hypophosphatemic rickets. Am J Dis Child 145:1165-1170.